Cargando…
New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data
The assessment of the cardiovascular safety profile of any newly developed antihyperglycemic drug is mandatory before registration, as a meta-analysis raised alarm describing a significant increase in myocardial infarction with the thiazolidinedione rosiglitazone. The first results from completed ca...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574229/ https://www.ncbi.nlm.nih.gov/pubmed/28894748 http://dx.doi.org/10.1155/2017/1253425 |